Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Cetuximab
Australian Public Assessment Report
Device/Product Name
Erbitux
Active ingredients
Cetuximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2012-00340-3-4
Submission Type
Major variation (review of indications, changes to Product Information)
Decision
Approved